filmov
tv
Facial Angiofibroma Associated with TSC and How Can it Be Managed?
Показать описание
Presenter: Joyce M. C. Teng, MD, PhD, Professor of Dermatology & Pediatrics, Stanford University
Moderator: Eric Beresford, PharmD, BCMAS, Vice President and Head of Medical Affairs, Nobelpharma America
Facial angiofibroma is one of the most visible signs of tuberous sclerosis complex (TSC) and occurs in approximately 75%-80% of TSC patients. If left untreated, facial angiofibroma can cause disfigurement. Patients have reported that facial angiofibroma can have negative effects on appearance and self-image, and the tumors may be a psychological and social burden for people living with this condition.
In this webinar session, Dr. Joyce Teng, Professor of Dermatology and Pediatrics, Stanford University and Eric Beresford, Vice President and Head of Medical Affairs, Nobelpharma America, guide attendees in exploring:
1. What Is Facial Angiofibroma Associated with TSC?
2. The Social and Psychological Impact of Facial Angiofibroma
3. Taking Care of Your Skin
4. What to Know About Treatments
This webinar was sponsored by Nobelpharma America, LLC.
Moderator: Eric Beresford, PharmD, BCMAS, Vice President and Head of Medical Affairs, Nobelpharma America
Facial angiofibroma is one of the most visible signs of tuberous sclerosis complex (TSC) and occurs in approximately 75%-80% of TSC patients. If left untreated, facial angiofibroma can cause disfigurement. Patients have reported that facial angiofibroma can have negative effects on appearance and self-image, and the tumors may be a psychological and social burden for people living with this condition.
In this webinar session, Dr. Joyce Teng, Professor of Dermatology and Pediatrics, Stanford University and Eric Beresford, Vice President and Head of Medical Affairs, Nobelpharma America, guide attendees in exploring:
1. What Is Facial Angiofibroma Associated with TSC?
2. The Social and Psychological Impact of Facial Angiofibroma
3. Taking Care of Your Skin
4. What to Know About Treatments
This webinar was sponsored by Nobelpharma America, LLC.
0:59:55
Facial Angiofibroma Associated with TSC and How Can it Be Managed?
0:49:10
Caring for a loved one with facial angiofibroma associated with TSC
0:42:17
Tuberous Sclerosis and the Skin, including emerging treatments for facial angiofibromas
0:00:10
Potential new treatment for TSC
0:58:36
Timber Pharmaceuticals: Research Update & Roundtable Discussion on Treatment of Facial Angiofibr...
0:53:32
TSC and skin
0:00:31
FACIAL ANGIOFIBROMAS #neurocutaneous syndromes #dermatology #skincare #neetpg #tuberous_sclerosis
0:01:58
What are the Symptoms of Tuberous Sclerosis Complex?
0:57:34
Dermatologic Manifestations of TSC
0:04:49
Tuberous Sclerosis || Spot Diagnosis - 8 || Pediatrics
0:36:33
Track 3 TSC Adult -- Treating Skin Issues
0:00:12
Tuberous Sclerosis #angiofibroma
0:19:24
Einstein Tuberous Sclerosis Conference, Dr. Adam Levy (7 of 8)
0:02:04
Tuberous Sclerosis Complex - Treatments in the Pipeline
0:03:03
Tuberous Sclerosis Complex in 3 Minutes
0:00:15
#adenomasebaceum#tuberoussclerosis Adenoma sebaceum tuberous sclerosis
0:38:42
Racial Differences in TSC Skin Manifestations
0:04:27
Topical rapamycin–calcitriol for tuberous sclerosis complex, P.L. Chen et al
0:01:41
A Case of Tuberous Sclerosis | Clinical signs | Ashleaf spot | shahgreen patch | angiofibroma
0:02:32
TSC Talk: Did You Know?
1:03:57
Mosaicism in TSC
0:23:37
Our Common Goal: Improving Outcomes for People with TSC: Dr Elizabeth Thiele
1:23:23
Tuberous Sclerosis Complex
0:00:59
TSC Talks! Three on TSC, 'Why doesn't she have angiofibromas on her face?'
Комментарии